Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verification Study of Ciclosporin for Atopic Dermatitis
NCT00232076Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2004
- Primary completion
- Mar 2005
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 3 trial of cyclosporine microemulsion in atopic dermatitis (AD), sponsored by Novartis. Started May 2004; status: completed.
02
Drugs
cyclosporine microemulsion
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00232076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232076.